会计年度:2004-06-30收入分布
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 达芬霖 | 5,113,786.58 | 1,521,441.39 | 3,592,345.19 | 70.25 |
| 复方甘草合剂 | 8,489,585.26 | 5,778,345.51 | 2,711,239.75 | 31.94 |
| 肝乐宁 | 3,994,896.42 | 596,674.80 | 3,398,221.62 | 85.06 |
| 零售、批发收入 | 50,575,358.25 | 45,049,827.39 | 5,525,530.86 | 10.93 |
| 其他 | 17,088,190.93 | 6,747,804.58 | 10,340,386.35 | 60.51 |
| 麝香痔疮膏 | 56,640,402.15 | 15,503,051.04 | 41,137,351.11 | 72.63 |
| 麝香痔疮栓 | 25,883,507.23 | 3,271,895.07 | 22,611,612.16 | 87.36 |
| 斯普林 | 15,208,347.29 | 1,008,349.40 | 14,199,997.89 | 93.37 |
|
会计年度:2003-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 达芬拉露 | 2,202,874.15 | 660,589.92 | 1,542,284.23 | 70.01 |
| 达芬露 | 8,863,463.84 | 2,627,987.47 | 6,235,476.37 | 70.35 |
| 复方甘草合剂 | 27,926,540.68 | 15,851,650.45 | 12,074,890.23 | 43.24 |
| 肝乐宁 | 12,309,890.64 | 1,973,611.72 | 10,336,278.92 | 83.97 |
| 零售、批发收入 | 64,242,940.86 | 57,548,743.37 | 6,694,197.49 | 10.42 |
| 其他 | 38,751,782.96 | 16,105,604.49 | 22,646,178.47 | 58.44 |
| 麝香痔疮膏 | 110,568,926.88 | 30,185,454.36 | 80,383,472.52 | 72.70 |
| 麝香痔疮栓 | 39,519,428.13 | 4,985,744.04 | 34,533,684.09 | 87.38 |
| 斯普林 | 21,258,725.07 | 2,398,948.74 | 18,859,776.33 | 88.72 |
|
会计年度:2002-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 药品 | 248,116,916.92 | 84,984,530.24 | 163,132,386.68 | 65.75 |
|
会计年度:2001-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 药品 | 204,905,570.36 | 68,478,458.21 | 136,427,112.15 | 66.58 |
|
8/8 转到 
